CATALOGO DEI PRODOTTI DELLA RICERCA

SACERDOTI, David
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.951
AS - Asia 6.297
NA - Nord America 5.612
SA - Sud America 930
AF - Africa 116
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 6
AN - Antartide 1
Totale 19.933
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.492
RU - Federazione Russa 3.520
SG - Singapore 3.125
CN - Cina 1.502
GB - Regno Unito 952
BR - Brasile 732
HK - Hong Kong 575
FR - Francia 567
IE - Irlanda 535
VN - Vietnam 470
KR - Corea 291
UA - Ucraina 277
DE - Germania 270
IT - Italia 256
SE - Svezia 242
FI - Finlandia 145
ID - Indonesia 89
AR - Argentina 78
CA - Canada 60
EC - Ecuador 45
IN - India 42
BD - Bangladesh 41
MX - Messico 39
AT - Austria 36
PL - Polonia 29
TR - Turchia 28
ES - Italia 27
ZA - Sudafrica 25
NL - Olanda 24
JP - Giappone 23
CO - Colombia 22
TG - Togo 22
AU - Australia 19
BE - Belgio 18
BJ - Benin 17
CL - Cile 14
IQ - Iraq 13
PK - Pakistan 12
PE - Perù 11
VE - Venezuela 11
PY - Paraguay 10
AE - Emirati Arabi Uniti 9
DZ - Algeria 9
EG - Egitto 9
LT - Lituania 8
AZ - Azerbaigian 7
KZ - Kazakistan 7
MA - Marocco 7
UZ - Uzbekistan 7
JO - Giordania 6
KE - Kenya 6
NP - Nepal 6
RO - Romania 6
AL - Albania 5
TN - Tunisia 5
UY - Uruguay 5
CZ - Repubblica Ceca 4
DO - Repubblica Dominicana 4
HN - Honduras 4
IL - Israele 4
MY - Malesia 4
NO - Norvegia 4
SA - Arabia Saudita 4
CH - Svizzera 3
HU - Ungheria 3
IR - Iran 3
KG - Kirghizistan 3
KW - Kuwait 3
MD - Moldavia 3
OM - Oman 3
PH - Filippine 3
RS - Serbia 3
SY - Repubblica araba siriana 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
CR - Costa Rica 2
CW - ???statistics.table.value.countryCode.CW??? 2
CY - Cipro 2
GT - Guatemala 2
JM - Giamaica 2
KH - Cambogia 2
MK - Macedonia 2
NG - Nigeria 2
PA - Panama 2
PS - Palestinian Territory 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BS - Bahamas 1
BW - Botswana 1
BZ - Belize 1
CI - Costa d'Avorio 1
DK - Danimarca 1
Totale 19.912
Salva come PNG Salva come JPEG
Città #
Singapore 1.383
Moscow 966
Southend 844
Jacksonville 788
Ashburn 625
Dallas 576
Hong Kong 569
Chandler 548
Dublin 533
Beijing 280
Lawrence 262
Princeton 262
The Dalles 229
Wilmington 220
Los Angeles 150
Ho Chi Minh City 144
Jinan 121
Redondo Beach 111
Munich 105
Helsinki 98
Buffalo 96
Hanoi 88
Shenyang 81
Ann Arbor 80
Dong Ket 79
New York 71
São Paulo 68
Jakarta 62
Sindelfingen 59
Tianjin 58
Nanjing 52
Santa Clara 52
Ningbo 51
Changsha 50
Haikou 41
Hebei 41
Columbus 38
Hangzhou 38
San Francisco 38
Verona 37
Milan 36
Seattle 36
London 35
Houston 34
Zhengzhou 34
Guangzhou 33
Taizhou 32
Fairfield 30
Nanchang 30
Nuremberg 29
Brooklyn 28
Warsaw 28
Taiyuan 25
Norwalk 24
Redwood City 23
Turku 23
Boston 22
Lomé 22
Tokyo 22
Falkenstein 21
Lanzhou 21
Washington 21
Rio de Janeiro 19
Brussels 18
Council Bluffs 18
Toronto 18
Cotonou 17
Chicago 16
Da Nang 16
Denver 16
Guayaquil 16
Mexico City 16
Montreal 16
Vienna 16
Johannesburg 15
Lappeenranta 15
Redmond 15
Stockholm 15
Brasília 14
Jiaxing 14
Phoenix 14
San Diego 14
Belo Horizonte 13
Curitiba 13
Haiphong 13
Rome 13
Woodbridge 13
Fuzhou 12
Romola 12
Amsterdam 11
Atlanta 11
Charlotte 11
Chennai 11
Meda 11
Orem 11
Porto Alegre 11
San Jose 11
Biên Hòa 10
Frankfurt am Main 10
Hải Dương 10
Totale 11.128
Salva come PNG Salva come JPEG
Nome #
Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study (Internal and Emergency Medicine, (2018), 13, 5, (651-660), 10.1007/s11739-018-1835-9) 232
ALTERAZIONI DEI PARAMETRI ECO-COLOR-DOPPLER SPLANCNICI DI IPERTENSIONE PORTALE NELLA CIRROSI BILIARE PRIMITIVA E NELLA COLANGITE SCLEROSANTE: CONFRONTO CON LA CIRROSI POST-EPATICA E ALCOLICA 177
11,12-Epoxyeicosatrienoic acid stimulates heme-oxygenase-1 in endothelial cells 172
11,12-EET increases porto-sinusoidal resistance and may play a role in endothelial dysfunction of portal hypertension 171
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 145
Prevalence of peripheral artery disease by abnormal ankle-brachial index in atrial fibrillation: implications for risk and therapy 137
Accuracy and predictive value of echo-Doppler measurements in acute liver rejection -- initial experience 130
Alterations in thyroid Doppler arterial resistance indices, volume and hormones in cirrhosis: Relationships with splanchnic haemodynamics 129
Alterazioni circolatorie splancniche e periferiche nella cirosi: studio mediante eco-color-doppler. Risultati a lungo termine del Centro Trapianti di Padova. 127
A Pig Model of Hemivascular Liver Occlusion for The Study of Ischemia-Reperfusion Injury: Use of an Infrared System for Detecting Ischemic Areas 120
Interleukin-6: A New Marker of Advanced-Sarcopenic HCC Cirrhotic Patients 119
Arachidonic acid metabolites and endothelial dysfunction of portal hypertension 117
Arterioportal fistulas in patients with liver cirrhosis: Usefulness of color-Doppler US for screening 114
A CO-releaseng molecule, CORM-3, attenuates ischemia/reperfusion incurie in a new model in pig liver 111
Effects of direct-acting antiviral agents on lipid and glucose profile in HCV patients with type 2 diabetes: A real-life Italian experience 109
Assessment of intrarenal sodium handling by lithium clearance in cirrhotic patients with ascites 108
Ankle-Brachial Index and cardiovascular events in atrial fibrillation: The ARAPACIS study 106
I betabloccanti nel trattamento dell'ipertensione portale in corso di cirrosi epatica. Rapporti tra effetto sulla pressione portale e prevenzione della recidiva emorragica. 105
A pathophysiological interpretation of unresponsiveness to spironolactone in a stepped-care ap¬proach to the diuretic treatment of ascites in non-azotemic cirrhotics 104
Effetti della ciclosporina sulla funzione renale e sul metabolismo renale citocromo P450-dipendente dell'acido arachidonico. 103
Frequency of Left Ventricular Hypertrophy in Non-Valvular Atrial Fibrillation 101
Alteration in endothelial function in cirrhosis 100
Arteroportal fistulas between the accessory right hepatic, gastroduodenal and superior mesenteric arteries and portal vein: a difficult technical problem to overcome in liver transplantation 100
Duplex Doppler ultrasonography allows a multiorgan noninvasive approach to splanchnic pharmacodynamics in patients with cirrhosis 100
Subclinical and clinical atherosclerosis in Non-alcoholic Fatty Liver Disease is associated with the presence of hypertension 99
Carotid plaque detection improves the predictve value of CHA2DS2-VASc score in patients with non-valvular atrial fibrilation: The ARAPACIS Study 99
Metabolic-associated fatty liver disease and liver fibrosis scores as COVID-19 outcome predictors: a machine-learning application 96
Prevalence of portal vein thrombosis in non-alcoholic fatty liver disease: a meta-analysis of observational studies 94
Effetti del nadololo sull'emodinamica e sulla funzione renale, sul sistema renina-angiotensina-aldosterone e sulla produzione renale di PGE2 nei pazienti con cirrosi epatica ed ipertensione portale. 94
Atrogin-1 deficiency promotes cardiomyopathy and premature death via impaired autophagy 94
Splenic Doppler impedance indeces: influence of different portal hemodynamic conditions. 94
Differential effects of cyclosporine A on hepatic and renal cytocrom P450 dependent metabolism of arachidonic acid. 93
Spur cells in liver cirrhosis are predictive of acute-on-chronic liver failure and liver-related mortality regardless of severe anaemia 92
Q-T interval prolongation in liver cirrhosis - Reversibility after orthotopic liver transplantation 92
Alterazioni epatiche in corso di scompenso cardiaco 90
Bacterial infections as a risk factor for non-neoplastic portal vein thrombosis development in cirrhotic patients 89
Comparison of computer psychometric tests (CPTs) and number connection test (NCT) in the detection of subclinical hepatic encephalophaty (SHE). 89
Hepatic vein catheterization in the prognostic evaluation in cirrhotics with esophageal varices 89
Waiting list mortality and 5-year transplant survival benefit of patients with MASLD: An Italian liver transplant registry study 89
Aumento degli indici di resistenza arteriosa epatica nella cirrosi con e senza trombosi portale: rapporti con l'ipertensione portale. 88
Resistance to spironolactone in nonazotemic ascitic cirrhotic: role of enhanced proximal sodium reabsorption 88
Magnesium deficiency (MD) in liver cirrhosis evaluated by intravenous load 87
Heme-oxygenase-1 Induction Improves Type-1 Cardiorenal Syndrome Only In Mice With Impaired AngII-induced Lymphocyte Activation (SCID Mice) 87
Prevalence of portal vein thrombosis in non-alcoholic fatty liver disease: a meta-analysis of observational studies 87
T Regulatory Lymphocytes Function Increased, by Induction Of Ho-1, Improves Type-1 Cardio-Renal Syndrome 86
Hepatic decompensation is the major driver of mortality in patients with HCC treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment 85
Hypoalbuminemia and Risk of Portal Vein Thrombosis in Cirrhosis 84
Variability of atrial natriuretic peptide plasma levels in ascitic chirrotics; pathophysiological and clinical implications 84
Effects of cyclosporine on renal function and cytochrome P450 -dependent metabolites of arachidonic acid metabolism 84
A Phase 2a active-comparator-controlled study to evaluate the efficacy and safety of efinopegdutide in patients with nonalcoholic fatty liver disease 83
Atrial natriuretic peptide (hANP) plasma levels in ascitic cirrhotics; a better selection of patients is needed ? 83
Evaluation angiografique semiquantitative de la perfusion portale chez les cirrhotiques: relations avec le debit plasmatique hepatiqhe.[lettre] 83
Cholestatic HCV Cryoglobulinemia: A New Clinical and Pathological Entity before and after Direct-Acting Antiviral Therapies-A Case-Control Study 82
Confronto tra Captopril e Nifedipina per via sublinguale nel trattamento delle emergenze ipertensive. 82
Urinary excretion of P450-Hetes: increase of 20-Hete in patients with cirrhosis 82
Serological response and breakthrough infection after COVID-19 vaccination in patients with cirrhosis and post-liver transplant 81
Differential effects of cyclosporine A on hepatic and renal cytocrome P450 dependent metabolism of arachidonic acid. 81
HEPATIC VEINS DOPPLER PROFILE MODIFICATIONS DURING ACUTE PORTAL PRESSURE INCREASE INDUCED BY PARAUMBILICAL VEIN COMPRESSION 81
The multi-drug resistant organisms infections decrease during the antimicrobial stewardship era in cirrhotic patients: An Italian cohort study 79
Role of prostaglandins in the response to diuretic treatment of ascites in cirrhotic patients. 79
La vasocostrizione renale in corso di cirrosi epatica: studio mediante eco-color doppler 79
Effect of a dietary integration with BCAA or casein on nutritional state and lower limb amino acid exchange in cirrhosis 79
Left ventricular diastolic function in liver cirrhosis 79
Relationship between renal prostaglandins and renal response to maximal water load in non ascitic liver cirrhosis. 77
Vasocostrizione renale in corso di cirrosi epatica: studio mediante eco-color doppler. 77
Renal function in congestive heart failure. 77
Role of prostaglandins in the response to diuretic treatment of ascites in cirrhotic patients. 77
Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis 77
Renal vasoconstriction in cirrhosis evaluated by duplex Doppler ultrasonography 76
Drugs in the prevention of rebleeding in cirrhosis 76
SPLENO-SYSTEMIC SHUNTS AND COVERT HEPATIC ENCEPHALOPATY 76
Hepatofugal portal flow is highly predictive of acute-on-chronic liver failure: A new hemodynamic patho-physiological hypothesis 75
Diagnostic accuracy of AGILE 3+ score for advanced fibrosis in patients with NAFLD: A systematic review and meta-analysis 75
Renal cytochrome P450-dependent metabolism of arachidonic acid in experimental liver cirrhosis 75
Effetti del defribotide sulla funzione renale in ratti trattati conciclosporina 75
Mesenteric arteries responsiveness to acute variations of wall shear stress is impaired in rats with liver cirrhosis 75
Prognostic usefulness of hepatic vein catheterization in patients with cirrhosis and esophageal va¬rices 75
Comparison of Fondaparinux and Low-Molecular-Weight Heparin in the Treatment of Portal Vein Thrombosis in Cirrhosis 75
Myosteatosis is closely associated with sarcopenia and significantly worse outcomes in patients with cirrhosis 74
Urinary excretion of P450-Hetes: increase of 20-Hete in patients with cirrhosis 74
Effectiveness of a stepped care approach to diuretic treatment of ascites in cirrhotic patients 74
Effect of nadolol on liver haemodynamics and function in patients with cirrhosis 74
Interobserver and interequipment variability of hepatic, splenic, and renal arterial Doppler resistance indices in normal subjects and patients with cirhosis. J Hepatol 1997; 27: 986-992 (IF=4.974) 74
Hepatic vein catheterization in the prognostic evaluation in cirrhotics with esophageal varices. 74
Incidence and Recurrence of Portal Vein Thrombosis in Cirrhotic Patients 74
Effetti dell'Iloprost sull'emodinamica renale, sul metabolismo intrarenale del sodio e sul sistema renina-angiotensina-aldosterone. 73
Effetto protettivo del corm-3 nei confronti del danno da ischemia-riperfusione in un modello sperimentale porcino 73
Severe reduction of blood lysosomal acid lipase activity in cryptogenic cirrhosis: A nationwide multicentre cohort study 73
Vascular perfusion kinetics by contrast-enhanced ultrasound are related to synovial microvascularity in the joints of psoriatic arthritis 73
Glomerular Hyperfiltration: A Marker of Fibrosis Severity in Metabolic Associated Steatotic Liver Disease in an Adult Population 72
Vascular disorders of the liver: recommendations from the Italian Association for the Study of the Liver (AISF) ad hoc committee 72
The safety of Sonovue in abdominal applications: retrospective analysis of 23188 investigations 72
Author's Reply: “Bacterial infections predispose to the development of portal vein thrombosis in patients with decompensated cirrhosis” 71
Hepatic arterial resistance in cirrhosis with and without portal vein thrombosis. 71
Efficacia di un trattamento diuretico organizzato per "steps" nella terapia dell'ascite in corso di cirrosi epatica. 71
La profilassi primaria dell'emorragia da rottura di varici esofagee 71
intrahepatic arterioportal fistulas in cirrhosis: usefulness of echo-Doppler as screening procedure 71
Platelets in Non-alcoholic Fatty Liver Disease 71
Role of prostaglandins in the response to diuretic treatment of ascites in cirrhotic patients. 70
PGE2 renali e metabolismo del sodio e dell'acqua nella cirrosi epatica anascitica 70
Totale 9.153
Salva come PNG Salva come JPEG
Categoria #
all - tutte 87.037
article - articoli 68.460
book - libri 856
conference - conferenze 13.532
curatela - curatele 0
other - altro 466
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.723
Totale 174.074
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021777 0 0 0 0 0 295 23 9 12 8 332 98
2021/20221.598 104 209 11 23 111 21 54 116 108 116 238 487
2022/20232.483 283 156 347 236 379 701 15 101 162 10 49 44
2023/20241.224 52 86 86 113 70 198 129 77 2 63 251 97
2024/20254.564 298 280 183 803 163 51 110 480 523 244 361 1.068
2025/20267.859 1.149 687 692 1.848 2.728 755 0 0 0 0 0 0
Totale 20.365